NXTC NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

NextCure  Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 4.14 USD
-2.2% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -51.8% below the Trend Line and sits at 18.3% of its 52-week range. The latest completed week returned -2.2%, after a 120.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.

Setup score 30 out of 100
Latest Close 4.14 USD 31 Jul 2026
1W Return -2.2% latest completed week
4W Return 120.5% short-term follow-through
12W Return -57.5% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.2% Latest completed week; four-week move 120.5%. Indicator stack 26/42 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.02% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 47/100 50 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -51.8% below the Trend Line and sits at 18.3% of its 52-week range. The latest completed week returned -2.2%, after a 120.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.14

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 120.5% over four weeks, -57.5% over 12 weeks, and -15.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.2%
4W120.5%
12W-57.5%
26W-61.8%
52W-15.2%
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.71Latest activity-pressure read.
Pressure change57.4%Four-week change in activity pressure.
Leadership-56.83Latest relative-leadership reading.
RS change30.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 61% Model confidence 58%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength49/100Blend of value, momentum, and quality. Underlying universe rank 52; rank 1 is best.
Value49/100Relative valuation strength. Underlying universe rank 52; rank 1 is best.
Quality47/100Profitability and accounting quality. Underlying universe rank 54; rank 1 is best.
Momentum49/100Medium-term price momentum. Underlying universe rank 52; rank 1 is best.
Growth49/100Revenue and earnings growth. Underlying universe rank 52; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-248.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity6 / 0

6 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment47/100

Weighted news tone is neutral across 50 relevant articles.

8 positive · 30 neutral · 12 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-73.7%Distance below the 52-week high.
13-week volatility60.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+204.1%Week of 17 Jul.
Worst week-52.4%Week of 5 Jun.
Latest week-2.2%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains4
Flat weeks0
Modest losses4
Sharp losses10
Recent vol60.3%13-week weekly-return volatility.
Base vol33.8%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew17.8% / -13.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape21/100

Trend, activity pressure, participation, and risk combine to a 21/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 40.02%

Next-week expectancy is negative with a 40.02% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors47/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment47/100

Weighted news tone is neutral across 50 relevant articles.

NextCure Inc (NXTC) Cash Flow Insiders6 / 0

6 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20264.14 USD-2.2%8.59 USD12.21 USD-0.71-56.832.9MOff
24 Jul 20264.24 USD-29.2%8.90 USD12.32 USD-1.02-55.772.6MOff
17 Jul 20265.99 USD204.1%9.18 USD12.42 USD-1.29-38.91120.0MOff
10 Jul 20261.97 USD4.8%9.36 USD12.52 USD-1.70-80.75374.2KOff
3 Jul 20261.88 USD14.3%9.67 USD12.64 USD-1.66-81.45414.1KOff
26 Jun 20261.65 USD-18.6%10.02 USD12.77 USD-1.62-83.78612.9KOff
19 Jun 20262.02 USD-2.7%10.43 USD12.90 USD-1.65-81.17578.4KOff
12 Jun 20262.08 USD-29.7%10.71 USD13.01 USD-1.68-80.34784.9KOff
5 Jun 20262.95 USD-52.4%10.97 USD13.12 USD-1.62-71.881.5MOff
29 May 20266.20 USD-20.8%11.17 USD13.23 USD-1.53-44.07226.9KOff
22 May 20267.83 USD-19.6%11.39 USD13.32 USD-1.44-27.61222.3KOff
15 May 20269.74 USD-0.2%11.43 USD13.40 USD-1.16-8.98106.2KOff
8 May 20269.76 USD4.3%11.51 USD13.48 USD-1.06-8.67171.8KOff
1 May 20269.36 USD-11.0%11.40 USD13.55 USD-0.88-7.27208.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.